What is Cord Tissue Banking?
The cord tissue is rich in powerful healing stem cells and contains the cells and signals required for regenerative medicine applications. It contains mesenchymal stem cells (MSCs), but also other types of stem cells including epithelial and endothelial stem cells. MSCs are multipotent stem cells capable of differentiating into a number of different cell and tissue types. The cord tissue also contains growth factors and cytokines. Growth factors are signaling molecules that regulate cell growth and tissue regeneration, while cytokines are signaling molecules that regulate inflammation.
What is the Umbilical Cord?
What are Mesenchymal Stem Cells?
The Difference Between Cord Tissue and Cord Blood Banking
The primary intent of cord blood banking is to isolate and cryogenically preserve hematopoietic stem cells (HSCs) found in cord blood. Whereas the primary intent of cord tissue banking is to process and cryogenically preserve the cord tissue which contains mesenchymal stem cells (MSCs), growth factors, and cytokines.
Cord blood HSCs are FDA-approved to treat over 80 blood-related diseases and disorders. Treatments include various types of blood cancers and disorders and metabolic and immune disorders. In addition, there are 100s of ongoing clinical trials researching treatment options using HSCs for neurological disorders, traumatic brain injuries, cardiovascular disease, and autoimmune disorders.
Cord tissue is more versatile due to it containing MSCs, growth factors, and cytokines. It has potential applications that are distinct from applications using cord blood HSCs. There are 100s of clinical trials researching treatment options for Alzheimer’s disease, diabetes, Parkinson’s disease, and orthopedic diseases and disorders.
Together, cord blood and cord tissue could be the future of regenerative medicine. Many expectant parents choose to preserve both to provide the widest potential scope of treatment options for the future.
Americord CryoMaxx™ Cord Tissue Processing
Many blood banks focus only on preserving the MSCs and pre-process them prior to cryopreservation, limiting future treatment options. Americord continues to stay up-to-date with new advances in regenerative medicine and has developed an innovative, new processing method: Americord CryoMaxx™.
Americord’s CryoMaxx™ processing method unlocks the full potential of umbilical cord tissue. The process uses a minimal manipulation method to enable the cord tissue to retain its inherent multipotent cells, growth factors, and cytokines. The cord tissue is cryopreserved as a membrane. It contains living cells and bioactive factors and is stored in multiple vials, which ensures the potential for multiple uses or applications. The cryopreserved cord tissue can be used for surgical applications or be processed in the future using the latest cell isolation techniques.
Americord’s CryoMaxx™ processing brings peace of mind to families and gives doctors and patients the flexibility to use the cord tissue stem cells for a wide range of therapeutic applications.
Clinical Trials Using Cord Tissue
Cord derived MSCs are currently being studied in hundreds of clinical trials.
Non-Blood Related Disorders
Pulmonary Inflammation and Infection
Graft Versus Host Disease
Refractory Immune Thrombocytopenia
Clinical Trials Using Cord Tissue in Surgery
Cord tissue, consisting of cells, growth factors, and cytokines, is currently being studied in a number of clinical trials for surgical applications. Clinical trials in progress are evaluating the power of cord tissue producing less surgical scarring and encouraging improved healing.
Arthroscopic Rotator Cuff Repair
Lumbar Discogenic Pain
Wounds & Injuries
Caesarean Section Scars
Spinal Cord Injuries
The Future is Bright
Questions About Cord Tissue
Cord tissue contains MSCs, which are a key component in regenerative medicine. These stem cells have the potential to repair and regenerate damaged tissues and organs, offering hope for treating a wide range of medical conditions. Regenerative medicine applications include orthopedic issues, heart disease, spinal cord injuries, and more.
Our commitment to excellence is evident in our proprietary and cutting-edge processing method, CryoMaxx™ Processing. This revolutionary approach is designed to minimize manipulation, allowing the cord tissue to retain its innate multipotent cells, growth factors, and cytokines.
Through CryoMaxx™ Processing, we unlock the extraordinary healing potential inherent within the cord tissue. This advanced technique preserves the essential components that make cord tissue an invaluable resource for regenerative medicine, ensuring that it maintains its full therapeutic efficacy for potential future applications.
We employ a meticulous process to extract and isolate the Mesenchymal Stem Cells (MSCs) from the cord tissue. These invaluable cells undergo thorough viability testing to ensure their health and effectiveness. Once verified, they are preserved through cryogenic freezing in state-of-the-art vapor nitrogen tanks.
What sets our approach apart is the storage method. The cord tissue is carefully divided into multiple vials, creating the potential for numerous applications and uses. This strategy maximizes the utility of the preserved cord tissue, allowing for flexibility and multiple opportunities to harness its regenerative and therapeutic potential.
Cord tissue stem cells, specifically mesenchymal stem cells (MSCs), are indeed making significant strides in the field of regenerative medicine. They hold immense promise for a wide range of medical conditions and therapies and are currently being used in hundreds of clinical trials including Cerebral Palsy, surgical applications, and more.
Your baby's cord tissue holds the potential to benefit both immediate family members, such as parents and siblings, as well as second-degree family members, like grandparents. This means that not only can it provide essential support to your closest loved ones, but also offer a valuable resource for relatives beyond your immediate family circle.
Banking both cord blood and cord tissue presents an exceptional opportunity to secure a diverse range of life-saving stem cells and regenerative resources for your baby's future. These perinatal tissues, rich in multi-potent stem cells, growth factors, cytokines, and extracellular matrix proteins, hold the potential to treat over eighty medical conditions and are actively studied in numerous clinical trials.
Moreover, the combination of cord blood hematopoietic stem cells and cord tissue mesenchymal stem cells offers a synergistic approach with the potential for therapeutic benefits surpassing today's treatments. Making the choice to bank both cord blood and cord tissue is a forward-thinking investment in your child's health, with opportunities for groundbreaking clinical applications today and in the future.